OptimizeRx Corp·4

Mar 4, 9:16 AM ET

Odence-Ford Marion 4

4 · OptimizeRx Corp · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-03-01
Odence-Ford Marion
Chief Legal & Admin Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-017710 total
    Common Stock (771 underlying)
  • Tax Payment

    Common Stock

    2025-03-01$5.18/sh268$1,38870,276 total
  • Exercise/Conversion

    Common Stock

    2025-03-01+77170,544 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
  • [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F3]The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.

Documents

1 file
  • 4
    wk-form4_1741097805.xmlPrimary

    FORM 4